These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25027841)

  • 1. Diagnostic accuracy of segmental enhancement inversion for the diagnosis of renal oncocytoma using biphasic computed tomography (CT) and multiphase contrast-enhanced magnetic resonance imaging (MRI).
    Schieda N; Al-Subhi M; Flood TA; El-Khodary M; McInnes MD
    Eur Radiol; 2014 Nov; 24(11):2787-94. PubMed ID: 25027841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of segmental enhancement inversion on biphasic MDCT between small renal oncocytomas and chromophobe renal cell carcinomas.
    Woo S; Cho JY; Kim SH; Kim SY
    AJR Am J Roentgenol; 2013 Sep; 201(3):598-604. PubMed ID: 23971452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Segmental enhancement inversion at biphasic multidetector CT: characteristic finding of small renal oncocytoma.
    Kim JI; Cho JY; Moon KC; Lee HJ; Kim SH
    Radiology; 2009 Aug; 252(2):441-8. PubMed ID: 19508984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI features of renal oncocytoma and chromophobe renal cell carcinoma.
    Rosenkrantz AB; Hindman N; Fitzgerald EF; Niver BE; Melamed J; Babb JS
    AJR Am J Roentgenol; 2010 Dec; 195(6):W421-7. PubMed ID: 21098174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.
    Amin J; Xu B; Badkhshan S; Creighton TT; Abbotoy D; Murekeyisoni C; Attwood KM; Schwaab T; Hendler C; Petroziello M; Roche CL; Kauffman EC
    Clin Cancer Res; 2018 Aug; 24(16):3898-3907. PubMed ID: 29752278
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential diagnosis of renal oncocytoma and chromophobe renal cell carcinoma using CT features: a central scar-matched retrospective study.
    Li X; Nie P; Zhang J; Hou F; Ma Q; Cui J
    Acta Radiol; 2022 Feb; 63(2):253-260. PubMed ID: 33497276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
    Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
    AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of segmental enhancement inversion for diagnosis of renal oncocytoma at biphasic contrast enhanced CT: systematic review.
    Schieda N; McInnes MD; Cao L
    Eur Radiol; 2014 Jun; 24(6):1421-9. PubMed ID: 24663821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination of oncocytoma and chromophobe renal cell carcinoma using MRI.
    Akın IB; Altay C; Güler E; Çamlıdağ İ; Harman M; Danacı M; Tuna B; Yörükoğlu K; Seçil M
    Diagn Interv Radiol; 2019 Jan; 25(1):5-13. PubMed ID: 30644365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small renal oncocytomas: is segmental enhancement inversion a characteristic finding at biphasic MDCT?
    O'Malley ME; Tran P; Hanbidge A; Rogalla P
    AJR Am J Roentgenol; 2012 Dec; 199(6):1312-5. PubMed ID: 23169723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Aorta-Lesion-Attenuation Difference on Preoperative Contrast-enhanced Computed Tomography Scan to Differentiate Between Malignant and Benign Renal Tumors.
    Grajo JR; Terry RS; Ruoss J; Noennig BJ; Pavlinec JG; Bozorgmehri S; Crispen PL; Su LM
    Urology; 2019 Mar; 125():123-130. PubMed ID: 30552939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Multiparametric MRI Useful for Differentiating Oncocytomas From Chromophobe Renal Cell Carcinomas?
    Galmiche C; Bernhard JC; Yacoub M; Ravaud A; Grenier N; Cornelis F
    AJR Am J Roentgenol; 2017 Feb; 208(2):343-350. PubMed ID: 27959744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas.
    Cornelis F; Lasserre AS; Tourdias T; Deminière C; Ferrière JM; Le Bras Y; Grenier N
    AJR Am J Roentgenol; 2013 Apr; 200(4):830-8. PubMed ID: 23521457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
    Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
    Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is segmental enhancement inversion on enhanced biphasic MDCT a reliable sign for the noninvasive diagnosis of renal oncocytomas?
    McGahan JP; Lamba R; Fisher J; Starshak P; Ramsamooj R; Fitzgerald E; Yen P
    AJR Am J Roentgenol; 2011 Oct; 197(4):W674-9. PubMed ID: 21940539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voxel-based whole-lesion enhancement parameters: a study of its clinical value in differentiating clear cell renal cell carcinoma from renal oncocytoma.
    Chen F; Gulati M; Hwang D; Cen S; Yap F; Ugwueze C; Varghese B; Desai M; Aron M; Gill I; Duddalwar V
    Abdom Radiol (NY); 2017 Feb; 42(2):552-560. PubMed ID: 27595574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of aorta-lesion-attenuation difference on preoperative contrast-enhanced computed tomography scan to differentiate between malignant and benign oncocytic renal tumors.
    Grajo JR; Batra NV; Bozorgmehri S; Magnelli LL; Pavlinec J; O'Malley P; Su LM; Crispen PL
    Abdom Radiol (NY); 2021 Jul; 46(7):3269-3279. PubMed ID: 33665734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula.
    Kopp RP; Aganovic L; Palazzi KL; Cassidy FH; Sakamoto K; Derweesh IH
    Can J Urol; 2013 Jun; 20(3):6790-7. PubMed ID: 23783049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT.
    Sasaguri K; Takahashi N; Gomez-Cardona D; Leng S; Schmit GD; Carter RE; Leibovich BC; Kawashima A
    AJR Am J Roentgenol; 2015 Nov; 205(5):999-1007. PubMed ID: 26496547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.